Senior insider sale
EVP, Chief Financial Officer at GILEAD SCIENCES, INC. — senior position signals high conviction
$1.18M
9K shares
What this filing means
DICKINSON ANDREW D plans to sell 9K shares of GILEAD SCIENCES, INC. valued at approximately $1.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001950047-26-008208
Officer· EVP, Chief Financial Officer
Since Nov 2019
9K
Shares to sell
$1.18M
Approx. market value
3K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
1/31/2024
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2024 | Performance Shares Not Applicable | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3K
Market value
$389.8K
7/15/2026
—Completed
Units to sell
3K
Market value
$376.2K
6/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3K
Market value
$415.1K
8/17/2026
Total
Units
9K
Value
$1.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/15/2026 | 3K | $389.8K | — | Completed |
6/15/2026 | 3K | $376.2K | — | Completed |
| Planned — Approximate Date | ||||
8/17/2026 | 3K | $415.1K | NASDAQ | Planned |
| Total | 9K | $1.18M | ||